Zhankui S. Jia

No. 1 Jianshe East Road
Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Association between autoimmune diseases and male reproductive health: A mendelian randomization study.

Association between autoimmune diseases and male reproductive health: A mendelian randomization study.

Journal: Science progress

Published: July 16, 2026

A Modified "Cross-Stitch" Suturing Technique Is Associated with Shorter Warm Ischemia Time in Robot-Assisted Partial Nephrectomy.

A Modified "Cross-Stitch" Suturing Technique Is Associated with Shorter Warm Ischemia Time in Robot-Assisted Partial Nephrectomy.

Journal: Journal of endourology

Published: June 11, 2026

Multi-omics analysis suggests ZDHHC18 as a potential risk factor for clear cell renal cell carcinoma linked to myeloid DC morphology.

Multi-omics analysis suggests ZDHHC18 as a potential risk factor for clear cell renal cell carcinoma linked to myeloid DC morphology.

Journal: Discover oncology

Published: August 25, 2025

The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study.

The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study.

Journal: Cancer immunology, immunotherapy : CII

Published: March 27, 2025

Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell Carcinoma.

Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell Carcinoma.

Journal: Clinical genitourinary cancer

Published: January 30, 2025

Reversing enhancer RNA-mediated IKBKE gene repression enables synthetic anticancer immunity in prostate cancer models.

Reversing enhancer RNA-mediated IKBKE gene repression enables synthetic anticancer immunity in prostate cancer models.

Journal: The Journal of clinical investigation

Published: January 03, 2025

Development and validation of a prediction score for subtype diagnosis of primary aldosteronism.

Development and validation of a prediction score for subtype diagnosis of primary aldosteronism.

Journal: Chinese medical journal

Published: December 21, 2024

The Oncopromoting Gene RBM6 Inhibits Prostate Tumour Cell Migration During Epithelial-to-Mesenchymal Transition.

The Oncopromoting Gene RBM6 Inhibits Prostate Tumour Cell Migration During Epithelial-to-Mesenchymal Transition.

Journal: Journal of cellular and molecular medicine

Published: November 29, 2024

Secrets revealed by the skin: initial success of tislelizumab and targeted therapy in advanced renal cell carcinoma-a case report and literature review.

Secrets revealed by the skin: initial success of tislelizumab and targeted therapy in advanced renal cell carcinoma-a case report and literature review.

Journal: Translational andrology and urology

Published: August 15, 2024

SYT4 binds to SNAP25 to facilitate exosomal secretion and prostate cancer enzalutamide resistance.

SYT4 binds to SNAP25 to facilitate exosomal secretion and prostate cancer enzalutamide resistance.

Journal: Cancer science

Published: January 12, 2024

Bibliometric and Visualization Analysis of Stem Cell Therapy for Erectile Dysfunction.

Bibliometric and Visualization Analysis of Stem Cell Therapy for Erectile Dysfunction.

Journal: Drug design, development and therapy

Published: November 06, 2023

Prediction for recurrent non-muscle invasive bladder cancer.

Prediction for recurrent non-muscle invasive bladder cancer.

Journal: Cancer biomarkers : section A of Disease markers

Published: September 04, 2023

Showing 1-12 of 57

Last Updated: 09/26/2026